Tag: Cardiogenic Shock


NCSI Findings Regarding Right Ventricular Dysfunction

About 40% of AMICS Patients Develop Right Ventricular Dysfunction Dr. Babar Basir, an interventionalist at Henry Ford Hospital and one of co-investigators for the National Cardiogenic Shock Initiative (NCSI), discusses the latest findings on right heart dysfunction from that initiative with Dr. Cathy Jeon. Dr. Basir explains that his work within the NCSI has sought … Continue reading “NCSI Findings Regarding Right Ventricular Dysfunction”

Where’s the Cardiogenic Shock Treatment Data?

Looking to Real-world Evidence in Cardiogenic Shock Dr. William O’Neill discusses cardiogenic shock treatment in light of the lack of randomized, controlled clinical trial data for cardiogenic shock. “There’s an inherent conflict of interest between the clinician and the scientist,” he tells interviewer Dr. Cathy Jeon. He explains that clinicians facing the life and death … Continue reading “Where’s the Cardiogenic Shock Treatment Data?”

The Importance of Early Intervention of Peripartum Cardiomyopathy

Dr. Uri Elkayam discusses Impella Support for PPCM Dr. Uri Elkayam discusses the importance of recognizing and treating peripartum cardiomyopathy (PPCM). He explains that the majority of patients who require mechanical circulatory support or transplant develop deterioration of heart function to the point where they present with cardiogenic shock.” Yet he emphasizes, “The potential for … Continue reading “The Importance of Early Intervention of Peripartum Cardiomyopathy”

Impella Support Pre-PCI for AMICS is Associated with Higher Survival in Women

Reference: J Interven Cardiol 2016; 29:248–256. Cardiogenic shock (CS) is the leading cause of death after acute myocardial infarction (AMI) and occurs in up to 10% of cases.1 Notably, the incidence of CS is higher in women presenting with STEMI than men (11.6% vs. 8.3%, p < 0.01).2   Previous studies evaluating the impact of CS … Continue reading “Impella Support Pre-PCI for AMICS is Associated with Higher Survival in Women”

Case Study Video: Right Ventricular Failure

Impella RP® Support for Univentricular Shock Dr. Navin Kapur, an interventional heart failure specialist at Tufts Medical Center, presents a case of univentricular shock in a 60-year-old patient with late presentation RVMI and 3 vessel disease. This case illustrates a hemodynamics-based decision-making process leading to optimal patient outcome. Dr. Kapur explains that his surgical team … Continue reading “Case Study Video: Right Ventricular Failure”

Biventricular Support in Procedural Cardiogenic Shock

Use of Impella RP and Impella 2.5 for MitraClip Procedure Dr. Kamran Muhammad discusses a challenging case illustrating the decision to use Impella RP® with Impella 2.5® to provide biventricular support. Dr. Muhammad is a subspecialist in interventional cardiology at Oklahoma Heart Institute in Tulsa, Oklahoma. The patient was an 81-year-old female presenting to the … Continue reading “Biventricular Support in Procedural Cardiogenic Shock”

INOVA Heart and Vascular Heart Recovery Initiative

Instituting a Cardiogenic Shock Protocol to Improve Outcomes Alexander Truesdell, MD and Behnam Tehrani, MD, interventional cardiologists at INOVA Heart and Vascular Institute discuss their experience implementing a cardiogenic shock protocol at INOVA. Data from their experience was recently published in the Journal of the American College of Cardiology. After Inova instituted a best practice … Continue reading “INOVA Heart and Vascular Heart Recovery Initiative”

Dr. Alexander Truesdell: “Team of Teams” for Treating Cardiogenic Shock

Dr. Alex Truesdell of Virginia Heart discusses how a “team of teams” approach to treating cardiogenic shock can standardize care and improve outcomes. He also discusses the recent improvement in cardiogenic shock survival at Inova Heart and Vascular. After Inova Heart and Vascular Institute instituted a best practice protocol that includes early use of percutaneous … Continue reading “Dr. Alexander Truesdell: “Team of Teams” for Treating Cardiogenic Shock”